| Literature DB >> 35715500 |
Isaiah Osei Duah Junior1, Michel Pascal Tchiakpe1, Lawrence Sheringham Borquaye2,3, Kwadwo Amoah4, Francis Kwaku Dzideh Amankwah5, David Ben Kumah1, Linda Aurelia Ofori6, Anthony Danso-Appiah7,8, Bright Owusu Prempeh1,9, Stephen Yao Gbedema5, Justin Munyaneza1, Cynthia Amaning Danquah10, Kwadwo Owusu Akuffo11.
Abstract
Empirical antimicrobial therapy is linked to a surge in antimicrobial resistant infections. However, an insight on the bacteria etiology of ocular infections is essential in the appropriation of choice of antimicrobial among clinicians, yet there remains a dearth of data from Ghana. We investigated the bacteria etiology of external ocular and periocular infections and antimicrobial treatment patterns among a Ghanaian ophthalmic population. A multicenter study design with purposive sampling approach was employed. Patients demographics and clinical data were collated using a pretested structure questionnaire. Cornea specimens and conjunctival swabs were obtained for bacterial isolation following standard protocols. About 95% (98/103) of ocular samples were positive for bacteria culture. The proportion of Gram-negative bacteria was 58.2%, and the predominant bacteria species were Pseudomonas aeruginosa 38.8% and Staphylococcus aureus 27.6%. Conjunctivitis 40.0% and keratitis 75.0% were mostly caused by Pseudomonas aeruginosa. The routinely administered antimicrobial therapy were polymyxin B 41.2%, neomycin 35.1% and ciprofloxacin 31.6%. Participants demographic and clinical characteristics were unrelated with positive bacteria culture (p > 0.05). Our results showed a markedly high burden of ocular bacterial infections and variations in etiology. Bacterial infection-control and antimicrobial agent management programs should be urgently institutionalized to prevent the emergence of resistant infections.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35715500 PMCID: PMC9206014 DOI: 10.1038/s41598-022-14461-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Description of the sample.
| Variables | Total (N = 114) | Males (N = 50, 43.9%) | Females (N = 64, 56.1%) | |
|---|---|---|---|---|
| % (frequency) | % (frequency) | % (frequency) | ||
| 0–2 | 21.1 (24) | 20.0 (10) | 21.9 (14) | 0.948 |
| 3–7 | 29.8 (34) | 32.0 (16) | 28.1 (18) | |
| 18–39 | 27.2 (31) | 28.0 (14) | 26.6 (17) | |
| ≥ 40 | 21.9 (25) | 20.0 (10) | 23.4 (15) | |
| Akan | 93.0 (106) | 90.0 (45) | 95.3 (61) | 0.271 |
| Northerner | 7.0 (8) | 10.0 (5) | 4.7 (3) | |
| Catholic | 13.2 (15) | 22.0 (11) | 6.3 (4) | 0.041 |
| Protestant | 80.7 (92) | 76..0 (38) | 84.4 (54) | |
| Muslim | 4.4 (5) | 2.0 (1) | 6.3 (4) | |
| Atheist | 1.8 (2) | 0.0 (0) | 3.1 (2) | |
| Rural | 59.6 (68) | 60.0 (30) | 59.4 (38) | 0.946 |
| Urban | 40.4 (46) | 40.0 (20) | 40.6 (26) | |
| None | 4.4 (5) | 4.0 (2) | 4.8 (3) | 0.943 |
| Preschool | 13.3 (15) | 12.0 (6) | 14.3 (9) | |
| Primary | 33.6 (38) | 30.0 (15) | 36.5 (23) | |
| Secondary | 29.2 (33) | 32.0 (16) | 27.0 (17) | |
| Tertiary | 8.0 (9) | 10.0 (5) | 6.3 (4) | |
| Not applicable* | 11.5 (13) | 12.0 (6) | 11.1 (7) | |
| Farming | 4.4 (5) | 6.0 (3) | 3.1 (2) | 0.092 |
| Wage/Salary worker | 7.0 (8) | 6.0 (3) | 7.8 (5) | |
| Construction worker | 2.6 (3) | 6.0 (3) | 0.0 (0) | |
| Dressmaking | 1.8 (2) | 0.0 (0) | 3.1 (2) | |
| Driver/Transport business | 2.6 (3) | 6.0 (3) | 0.0 (0) | |
| Businessman/woman | 5.3 (6) | 4.0 (2) | 6.3 (4) | |
| Welding | 1.8 (2) | 4.0 (2) | 0.0 (0) | |
| Trading | 8.8 (10) | 4.0 (2) | 12.5 (8) | |
| Beautician | 1.8 (2) | 0.0 (0) | 3.1 (2) | |
| Hairdressing | 2.6 (3) | 2.0 (1) | 3.1 (2) | |
| Student | 43.9 (50) | 46.0 (23) | 42.2 (27) | |
| Unemployed | 5.3 (6) | 2.0 (1) | 7.8 (5) | |
| Not applicable* | 12.3 (14) | 14.0 (7) | 10.9 (7) | |
| Not applicable* | 48.7 (55) | 50.0 (25) | 47.6 (30) | 0.936 |
| Single | 21.2 (24) | 24.0 (12) | 19.0 (12) | |
| Married | 21.2 (24) | 18.0 (9) | 23.8 (15) | |
| Cohabiting | 3.5 (4) | 4.0 (2) | 3.2 (2) | |
| Divorced | 2.7 (3) | 2.0 (1) | 3.2 (2) | |
| Separated | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Widow | 1.8 (2) | 2.0 (1) | 1.6 (1) | |
| Not applicable* | 44.7 (51) | 46.0 (23) | 43.8 (28) | 0.237 |
| Never smoked | 52.6 (60) | 48.0 (24) | 56.3 (36) | |
| Past smoker | 1.8 (2) | 4.0 (2) | 0.0 (0) | |
| Current smoker | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Not applicable* | 43.9 (50) | 42.0 (21) | 45.3 (29) | 0.054 |
| I never drink | 46.5 (53) | 40.0 (20) | 51.6 (33) | |
| I drink only on special occasions | 7.9 (9) | 14.0 (7) | 3.1 (2) | |
| I drink once or twice a week | 1.8 (2) | 4.0 (2) | 0.0 (0) | |
| None | 90.4 (103) | 82.0 (41) | 96.9 (62) | 0.027 |
| 1 unit | 6.1 (7) | 12.0 (6) | 1.6 (1) | |
| 2–5 unit | 3.5 (4) | 6.0 (3) | 1.6 (1) | |
| Diabetes | 4.4 (5) | 2.0 (1) | 6.3 (4) | 0.272 |
| Hypertension | 6.1 (7) | 4.0 (2) | 7.8 (5) | 0.4 |
| Tuberculosis | 0.9 (1) | 0.0 (0) | 1.6 (1) | 0.375 |
| Sexually transmitted diseases | 0.9 (1) | 2.0 (1) | 0.0 (0) | 0.256 |
| Peptic ulcer | 4.4 (5) | 2.0 (1) | 6.3 (4) | 0.272 |
| Others | 2.6 (3) | 6.0 (3) | 0.0 (0) | 0.047 |
| Not applicable* | 80.7 (92) | 82.0 (41) | 79.7 (51) | 0.915 |
| No | 2.6 (3) | 2.0 (1) | 3.1 (20 | |
| Yes | 16.7 (19) | 16.0 (8) | 17.2 (11) | |
| No | 82.5 (94) | 82.0 (41) | 82.8 (53) | 0.91 |
| Yes | 17.5 (20) | 18.0 (9) | 17.2 (11) | |
| Antibiotic | 3.5 (4) | 6.0 (3) | 1.6 (1) | 0.201 |
| Antidiabetic | 3.5 (4) | 2.0 (1) | 4.7 (3) | 0.439 |
| Antihypertensive | 5.3 (6) | 4.0 (2) | 6.3 (4) | 0.593 |
| Antimalarial | 0.9 (1) | 0.0 (0) | 1.6 (1) | 0.375 |
| Anticholesterol | 0.9 (1) | 2.0 (1) | 0.0 (0) | 0.256 |
| Others | 7.9 (9) | 8.0 (4) | 7.8 (5) | 0.971 |
*Under age; %, percentage frequency.
‡Northerner is a collective name for all ethnic group in the northern region of Ghana.
Clinical characteristics of external ocular and periocular infections among a Ghanaian ophthalmic population.
| Total (N = 114) | Males (N = 50, 43.9%) | Females (N = 64, 56.1%) | ||
|---|---|---|---|---|
| % (frequency) | % (frequency) | % (frequency) | ||
| Right eye; oculus dexter | 16.7 (19) | 22.0 (11) | 12.5 (8) | 0.369 |
| Left eye; oculus sinister | 16.7 (19) | 14.0 (7) | 18.8 (12) | |
| Both eyes; oculus uterque | 66.7 (76) | 64.0 (32) | 68.8 (44) | |
| Eyelid/eye lashes | 20.2 (23) | 22.0 (11) | 18.8 (12) | 0.668 |
| Conjunctiva | 94.7 (108) | 92.0 (46) | 96.9 (62) | 0.247 |
| Cornea | 18.4 (21) | 26.0 (13) | 12.5 (8) | 0.065 |
| Previous eye infections | 45.1 (51) | 44.0 (22) | 46.0 (29) | 0.829 |
| Previous use of antimicrobials | 55.8 (63) | 52.0 (26) | 58.7 (37) | 0.474 |
| Previous usage of contact lenses | 0.9 (1) | 0.0 (0) | 1.6 (1) | 0.371 |
| Previous use of spectacles | 9.7 (11) | 10.0 (5) | 9.5 (6) | 0.932 |
| Previous ocular trauma | 20.4 (23) | 30.0 (15) | 12.7 (8) | 0.023 |
| Previous ocular surgery | 2.7 (3) | 2.0 (1) | 3.2 (2) | 0.700 |
| < 1 week | 63.7 (72) | 66.0 (33) | 61.9 (39) | 0.649 |
| 2–4 weeks | 18.6 (21) | 20.0 (10) | 17.5 (11) | |
| > 4 weeks | 17.7 (20) | 14.0 (7) | 20.6 (13) | |
| Previous application of mascara | 6.2 (7) | 0.0 (0) | 11.1 (7) | 0.015 |
| Previous application of breastmilk | 2.7 (3) | 2.0 (1) | 3.2 (2) | 0.700 |
| Unavailable | 2.6 (3) | 2.0 (1) | 3.1 (2) | 0.939 |
| FFL | 23.7 (27) | 24.0 (12) | 23.4 (15) | |
| 6/5–6/18 | 63.2 (72) | 62.0 (31) | 64.1 (41) | |
| 6/24–6/60 | 7.9 (9) | 8.0 (4) | 7.8 (5) | |
| 3/60–1/60 | 2.6 (3) | 4.0 (2) | 1.6 (1) | |
| Unavailable | 2.6 (3) | 2.0 (1) | 3.1 (2) | 0.356 |
| FFL | 23.7 (27) | 24.0 (12) | 23.4 (15) | |
| 6/5–6/18 | 67.5 (77) | 66.0 (33) | 68.8 (44) | |
| 6/24–6/60 | 1.8 (2) | 0.0 (0) | 3.1 (2) | |
| 3/60–1/60 | 4.4 (5) | 8.0 (4) | 1.6 (1) | |
| Unavailable | 91.2 (104) | 86.0 (43) | 95.3 (61) | 0.266 |
| FFL | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| 6/5–6/18 | 7.0 (8) | 10.0 (5) | 4.7 (3) | |
| 3/60–1/60 | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Eye pain | 50.9 (58) | 42.0 (21) | 57.8 (37) | 0.094 |
| Itching | 60.5 (69) | 54.0(27) | 65.6 (42) | 0.208 |
| Falling lashes | 0.9 (1) | 0.0 (0) | 1.6 (1) | 0.375 |
| Lacrimation/watering | 61.4 (70) | 64.0 (32) | 59.4 (38) | 0.615 |
| Hyperemia/redness | 69.3 (79) | 72.0 (36) | 67.2 (43) | 0.580 |
| Swelling | 21.9 (25) | 22.0 (11) | 21.9 (14) | 0.987 |
| Discharge | 62.3 (71) | 70.0 (35) | 56.3 (33) | 0.133 |
| Burning sensation | 7.9 (9) | 6.0 (3) | 9.4 (6) | 0.507 |
| Foreign body sensation | 10.5 (12) | 14.0 (7) | 7.8 (5) | 0.285 |
| Others | 11.4 (13) | 4.0 (2) | 17.2 (11) | 0.028 |
| Visual acuity | 99.1 (113) | 98.0 (49) | 100 (64) | 0.256 |
| Slit lamp Biomicroscopy | 99.1 (113) | 98.0 (49) | 100 (64) | 0.256 |
| Ophthalmoscopy | 98.2 (112) | 98.0 (49) | 98.4 (63) | 0.860 |
| Microbial analysis | 90.4 (103) | 88.0 (44) | 92.2 (59) | 0.452 |
| Healthy | 98.2 (112) | 100.0 (50) | 96.9 (62) | 0.451 |
| Misdirected | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Crust formation | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Healthy | 66.7 (76) | 66.0 (33) | 67.2 (43) | 0.819 |
| Papillae | 17.5 (20) | 18.0 (9) | 17.2 (11) | |
| Cobblestones | 1.8 (2) | 2.0 (1) | 1.6 (1) | |
| Swelling | 11.4 (13) | 12.0 (6) | 10.9 (7) | |
| Crust | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Drooping | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Rashes | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Healthy | 26.3 (30) | 28.0 (14) | 25.0 (16) | 0.646 |
| Injection | 71.9 (82) | 72.0 (36) | 71.9 (46) | |
| Limbal papillae | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Limbal pigmentation | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Transparent | 87.7 (100) | 78.0 (39) | 95.3 (61) | 0.045 |
| Opacities | 3.5 (4) | 4.0 (2) | 3.1 (2) | |
| Laceration | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Abrasions | 7.0 (8) | 14.0 (7) | 1.6 (1) | |
| Ulcer | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Healthy | 83.3 (95) | 78.0 (39) | 87.5 (56) | 0.177 |
| Pigmented | 16.7 (19) | 22.0 (11) | 12.5 (8) | |
| Deep | 98.2 (112) | 96.0 (48) | 100 (64) | 0.106 |
| Shallow | 1.8 (2) | 4.0 (2) | 0.0 (0) | |
| Healthy (PERLLA) | 99.1 (113) | 98.0 (49) | 100.0 (64) | 0.256 |
| Abnormal (RAPD) | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Health (Dark and flat) | 99.1 (113) | 98.0 (49) | 100.0 (64) | 0.256 |
| Prolapse | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Transparent | 94.7 (108) | 92.0 (46) | 96.9 (62) | 0.247 |
| Opacities | 5.3 (6) | 8.0 (4) | 3.1 (2) | |
| None | 7.9 (9) | 6.0 (3) | 9.4 (6) | 0.351 |
| 1 | 33.3 (38) | 38.0 (19) | 29.7 (19) | |
| 2 | 40.4 (44) | 44.0 (22) | 37.5 (24) | |
| ≥ 3 | 18.4 (21) | 12.0 (6) | 23.4 (15) | |
| Conjunctivitis | 60.5 (69) | 52.0 (26) | 67.2 (43) | 0.216 |
| Blepharoconjuntivitis | 9.6 (11) | 10.0 (5) | 9.4 (6) | |
| Keratoconjunctivitis | 11.4 (13) | 16.0 (8) | 7.8 (5) | |
| Ophthalmia neonatorum | 0.9 (1) | 2.0 (1) | 0.0 (0) | |
| Ocular trauma | 6.1 (7) | 8.0 (4) | 4.7 (3) | |
| Preseptal cellulitis | 0.9 (1) | 0.0 (0) | 1.6 (1) | |
| Hordeolum | 2.6 (3) | 0 (0.0) | 3 (4.7) | |
| Keratitis | 7.9 (9) | 6 (12.0) | 3 (4.7) | |
| Dry eye syndrome | 10.5 (12) | 6.0 (3) | 14.1 (9) | 0.164 |
| Pterygium | 4.4 (5) | 4.0 (2) | 4.7 (3) | 0.859 |
| Pingueculum | 0.9 (1) | 0.0 (0) | 1.6 (1) | 0.375 |
| Headaches | 5.3 (6) | 8.0 (4) | 3.1 (2) | 0.247 |
FFL fixate-and-follow light, PERLLA pupils are equal, round, and reactive to light and accommodation, RAPD relative afferent pupillary defect.
Antimicrobial treatment of external ocular and periocular infections in a Ghanaian ophthalmic population.
| Types of clinical presentation | Bacteria culture results n (%) | Antimicrobial therapy employed in treating external ocular and periocular infections n (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Positive | Negative | RFR | CIP | GTM | PoB | NM | TBM | TX | OTX | OFC | FX | |
| Conjunctivitis | 55 (94.8) | 3 (5.2) | 0 (0.0) | 22 (31.9) | 2 (2.9) | 29 (42.0) | 22 (31.9) | 13 (18.8) | 16 (23.2) | 12 (2.6) | 0 (0.0) | 0 (0.0) |
| Blepharoconjuntivitis | 11 (100.0) | 0 (0.0) | 0 (0.0) | 2 (18.2) | 0 (0.0) | 8 (72.7) | 5 (45.5) | 1 (9.1) | 2 (18.2) | 3 (27.3) | 0 (0.0) | 0 (0.0) |
| Keratoconjunctivitis | 12 (92.3) | 1 (7.7) | 0 (0.0) | 2 (15.4) | 0 (0.0) | 5 (38.5) | 9 (69.2) | 0 (0.0) | 4 (30.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Ophthalmia neonatorum | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) |
| Ocular trauma | 7 (100.0) | 0 (0.0) | 1 (14.3) | 3 (42.9) | 0 (0.0) | 1 (14.3) | 1 (14.3) | 0 (0.0) | 2 (28.6) | 0 (0.0) | 0 (0.0) | 1 (14.3) |
| Preseptal cellulitis | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
| Hordeolum | 3 (100.0) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 1 (33.3) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (100.0) |
| Keratitis | 8 (88.9) | 1 (11.1) | 0 (0.0) | 6 (66.7) | 1 (11.1) | 2 (22.2) | 1 (11.1) | 1 (11.1) | 3 (33.3) | 2 (22.2) | 1 (11.1) | 0 (0.0) |
| Total | 98 (95.1) | 5 (4.4) | 1 (0.9) | 36 (31.6) | 3 (2.6) | 47 (41.2) | 40 (35.1) | 16 (14.0) | 28 (24.6) | 18 (15.8) | 1 (0.9) | 5 (4.4) |
n frequency, % percentage frequency, RFR referral, CIP ciprofloxacin, GTM gentamycin, PoB polymyxin B, NM neomycin, TBM tobramycin, TX tetracycline, OXT oxytetracycline, OFC ofloxacin, FX flucoxacillin .
Distribution of bacteria isolates across different clinical presentations of external ocular and periocular infections in a Ghanaian ophthalmic population.
| Bacteria isolates | Types of clinical presentation | Total isolates n (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Conjunctivitis n (%) | Blepharoconjuntivitis n (%) | Keratoconjunctivitis n (%) | Ophthalmia neonatorum n (%) | Ocular trauma n (%) | Preseptal cellulitis n (%) | Hordeolum n (%) | Keratitis n (%) | ||
| 12 (21.8) | 8 (72.7) | 4 (33.3) | 0 (0.0) | 1 (14.3) | 1 (100.0) | 0 (0.0) | 1 (12.5) | 27 (27.6) | |
| 8 (14.5) | 2 (18.2) | 1 (8.3) | 1 (100.0) | 1 (14.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 13 (13.3) | |
| 1 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | |
| 1 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (14.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (2.0) | |
| 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 1 (1.0) | |
| 1 (1.8) | 0 (0.0) | 1 (8.3) | 0 (0.0) | 1 (14.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (3.1) | |
| 1 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | |
| 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (14.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | |
| 22 (40.0) | 1 (9.1) | 5 (41.7) | 0 (0.0) | 2 (28.6) | 0 (0.0) | 2 (66.7) | 6 (75.0) | 38 (38.8) | |
| 9 (16.4) | 0 (0.0) | 1 (8.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (12.5) | 11(11.2) | |
| Total | 55 (56.1) | 11 (11.2) | 12 (12.2) | 1 (1.0) | 7 (7.1) | 1 (1.0) | 3 (3.1) | 8 (8.2) | 98 (100.0) |
n frequency, % percentage frequency, CONS coagulase-negative staphylococcal species.
Factors associated with external ocular and periocular infections among a Ghanaian ophthalmic population.
| Variable | Bivariate regression | p-value | |
|---|---|---|---|
| OR | 95% CI | ||
| Age (years) | 1.04 | 0.97–1.11 | 0.237 |
| 0–2 | Ref | ||
| 3–17 | 0.998 | ||
| 18–39 | 0.999 | ||
| ≥ 40 | 1.00 | 1.000 | |
| Man | Ref | ||
| Woman | 0.998 | ||
| Not applicable* | 0.998 | ||
| Male | Ref | ||
| Female | 0.32 | 0.03–2.97 | 0.316 |
| Akan | Ref | ||
| Northerner | 0.999 | ||
| Catholic | Ref | ||
| Protestant | 0.999 | ||
| Muslim | 1.00 | 1.000 | |
| Atheist | 1.00 | 1.000 | |
| Rural | Ref | ||
| Urban | 0.99 | 0.16–6.21 | 0.993 |
| None | Ref | ||
| Preschool | 1.00 | 1.000 | |
| Primary | 0.999 | ||
| Secondary | 0.999 | ||
| Tertiary | 1.00 | 1.000 | |
| Not applicable* | 1.00 | 1.000 | |
| Not applicable* | Ref | ||
| Student | 0.999 | ||
| Trading | 1.00 | 1.000 | |
| Welding | 1.00 | 1.000 | |
| Hairdressing | 1.00 | 1.000 | |
| Unemployed | 1.00 | 1.000 | |
| Construction worker | 1.00 | 1.000 | |
| Beautician | 1.00 | 1.000 | |
| Wage or salary worker | 1.00 | 1.000 | |
| Driver/Transport business | 1.00 | 1.000 | |
| Businessman/woman | 1.00 | 1.000 | |
| Farming | 1.00 | 1.000 | |
| Haidressing | 1.00 | 1.000 | |
| Not applicable* | Ref | ||
| Single | 2.24 | 0.24–21.29 | 0.481 |
| Married | 0.998 | ||
| Cohabiting | 0.999 | ||
| Divorced | 0.999 | ||
| Seperated | 1.000 | ||
| Widow | 0.999 | ||
| Not applicable* | Ref | ||
| Never smoker | 6.27 | 0.67–58.30 | 0.107 |
| Past smoker | 0.999 | ||
| Current smoker | 1.000 | ||
| Not applicable* | Ref | ||
| I never drink | 5.67 | 0.61–52.83 | 0.128 |
| I drink only on special occasions | 0.999 | ||
| I drink once or twice a week | 0.999 | ||
| None | Ref | ||
| 1 unit | 0.999 | ||
| 2–5 unit | 0.999 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 1.000 | ||
| No | Ref | ||
| Yes | 1.000 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 0.998 | ||
| Right eye; oculus dexter | Ref | ||
| Left eye; oculus sinister | 0.47 | 0.04–5.70 | 0.555 |
| Both eyes; oculus uterque | 1.75 | 0.15–20.42 | 0.655 |
| No | Ref | ||
| Yes | 0.998 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 0.36 | 0.06–2.31 | 0.282 |
| No | Ref | ||
| Yes | 0.19 | 0.02–1.77 | 0.145 |
| No | Ref | ||
| Yes | 0.998 | ||
| No | Ref | ||
| Yes | 1.000 | ||
| No | Ref | ||
| Yes | 0.46 | 0.05–4.53 | 0.505 |
| No | Ref | ||
| Yes | 0.998 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| < 1 week | Ref | ||
| 2–4 weeks | 0.998 | ||
| > 4 weeks | 1.22 | 0.13–11.62 | 0.863 |
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | 0.29 | 0.03–2.73 | 0.294 |
| No | Ref | ||
| Yes | 2.88 | 0.31–26.70 | 0.352 |
| No | Ref | ||
| Yes | 1.000 | ||
| No | Ref | ||
| Yes | 1.10 | 0.18–6.89 | 0.920 |
| No | Ref | ||
| Yes | 0.63 | 0.07–5.84 | 0.680 |
| No | Ref | ||
| Yes | 0.998 | ||
| No | Ref | ||
| Yes | 0.32 | 0.05–2.03 | 0.315 |
| No | Ref | ||
| Yes | 2.27 | 0.36–14.21 | 0.381 |
| No | Ref | ||
| Yes | 0.999 | ||
| No | Ref | ||
| Yes | |||
| 0.999 | |||
| No | Ref | ||
| Yes | 0.56 | 0.06–5.42 | 0.615 |
Bivariate regression analysis at a significance of p < 0.05.
OR odds ratio, CI confidence interval, Ref reference.
Figure 1Flow diagram illustrating study methodology.